Palbociclib plus cetuximab versus placebo plus cetuximab in platinum-resistant, cetuximab-naive, HPV-unrelated head and neck cancer: A double-blind randomized phase II trial (PALATINUS).

Douglas R. Adkins, Makoto Tahara, Assuntina G. Sacco et al.|Journal of Clinical Oncology|2019

Cited by 18